Ken Griffin Acorda Therapeutics Inc Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.55 - $1.0 $330 - $600
600 Added 2.49%
24,700 $14,000
Q4 2022

Feb 14, 2023
BUY
$0.52 - $0.77 $12,532 - $18,557
24,100 New
24,100 $18,000

Others Institutions Holding ACOR

# of Institutions
1
Shares Held
133K
Call Options Held
0
Put Options Held
0
View Full List

About ACORDA THERAPEUTICS INC

ACOR Quotes by TradingView
  • Ticker ACOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 24,338,400
  • Market Cap $6.33M
  • Description
  • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...
More about ACOR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email